Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction

Analytical Biochemistry

Volumn 278, Issue 2, 2000, Pages 175-184

  Johnson, Martin R ^a   Wang, Kangsheng ^a   Smith, Jeffrey B ^a   Heslin, Martin J ^b   Diasio, Robert B ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UAB Department of Surgery   (United States)

Author keywords

Dihydropyrimidine dehydrogenase; Pharmacogenetics; Pharmacogenomics; Quantitative RT PCR; Real time PCR; TaqMan

Indexed keywords

DYES; ENZYME ACTIVITY; RNA; TISSUE;

DIHYDROPYRIMIDINE DEHYDROGENASE; PHARMACOGENETICS; PHARMACOGENOMICS; QUANTITATIVE RT-PCR; REAL-TIME PCR; TAQMAN;

POLYMERASE CHAIN REACTION;

AMINO ACID; BETA ACTIN; DIHYDROPYRIMIDINE DEHYDROGENASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MAGNESIUM CHLORIDE; MESSENGER RNA;

AMINO ACID SEQUENCE; ARTICLE; COLORECTAL TUMOR; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HELA CELL; LIVER; MACROPHAGE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034651781     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1999.4461     Document Type: Article

References (36)

1. Scrip's Cancer Chemotherapy Report, 1996, Scrip World Pharmaceutical News, PJB Publications Ltd. London.
2. Grem J. L. Fluoropyrimidines. Chabner B. A., Longo D. L. Cancer Chemotherapy and Biotherapy. 1996;149-197 Lippincott-Raven, Philadelphia.
3. Heggie G. C., Sommadossi J. P., Cross D. S., Huster W. J., Diasio R. B. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res. 47:1987;2203-2206.
4. Lu Z., Zhang R., Diasio R. B. Purification and characterization of dihydropyrimidine dehydrogenase from human liver. J. Biol. Chem. 267:1992;17102-17109.
5. Kondo S. Apoptosis by antitumor agents and other factors in relation to cell cycle checkpoints. J. Radiat. Res. 36:1995;56-62.
6. Diasio R. B. Sorivudine and 5-fluorouracil: A clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase. Br. J. Clin. Pharmcol. 46:1998;1-4.
7. Morrison G. B., Bastian A., Dela-Rosa T., Diasio R. B., Takimoto C. H. Dihydropyrimidine dehydrogenase deficiency: A pharmacogenetic defect causing severe adverse reactions to 5-fluorouracil-based chemotherapy. Oncol. Nursing Forum. 24:1997;83-88.
8. Christensen E., Cezanne I., Kjaergaard S., Horlyk H., Faurholt-Pedersen V., Vreken P., van Kuilenburg A. B., Van Gennip A. H. Clinical variability in three Danish patients with dihydropyrimidine dehydrogenase deficiency all homozygous for the same mutation. J. Inherit. Metab. Dis. 21:1998;272-275.
9. Johnson M. R., Hageboutros A., Wang K., High L., Smith J. B., Diasio R. B. Life-threatening toxicity in a dihydropyrimidine dehydrogenase deficient patient following treatment with topical 5-fluorouracil. Clin. Cancer Res. 5:1999;2006-2011.
10. Wei X., McLeod H. D., McMurrough J., Gonzalez F. J., Salguero P. F. Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity. J. Clin. Invest. 98:1996;610-615.
11. Au J. L., Rustum Y. M., Ledesma E. J., Mittleman A., Creaven P. J. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas. Cancer Res. 42:1982;2930-2937.
12. Katona C., Kralovanszky J., Rosta A., Pandi E., Fonyad G., Toth K., Jeney A. Putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-fluorouracil in colorectal cancer patients. Oncology. 55:1998;468-474.
13. Zhang R., Lu Z., Liu T., Soong S., Diasio R. B. Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythm of pyrimidine enzymes: Possible relevance to fluoropyrimidine chemotherapy. Cancer Res. 53:1993;2816-2822.
14. Fleming R. A., Milano G., Thyss A., Etienne M. C., Renee N., Schneider M., Demard F. Correlation between dihydropyrimidine dehydrogenase activity in peripheral mononuclear cells and systemic clearance of fluorouracil in cancer patients. Cancer Res. 52:1992;2899-2902.
15. Beck A., Etienne M. C., Cheradame S., Fischel J. L., Formento P., Renee N., Milano G. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur. J. Cancer. 30:1994;1517-1522.
16. Peters G. J., van Groeningen C. J., Pinedo H. M. Dihydropyrimidine dehydrogenase in livers from mouse and rat, and in human liver, colon tumors, and mucosa in relation to anabolism of 5-fluorouracil. Adv. Exp. Med. Biol. 431:1998;633-636.
17. Jiang W., Lu Z., He Y., Diasio R. B. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: Implication for 5-fluorouracil-based chemotherapy. Clin. Cancer Res. 3:1997;395-399.
18. Nita M. E., Tominaga O., Tsuruo T., Muto T. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer. Hepato-Gastroenterology. 45:1998;2117-2122.
19. Ishikawa Y., Kubota T., Otani Y., Watanabe M., Teramoto T., Kumai K., Kitajima M., Takechi T., Okabe H., Fukushima M. Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice. Clin. Cancer Res. 5:1999;883-889.
20. Kirihara Y., Yamamoto W., Toge T., Nishiyama M. Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells. Int. J. Oncol. 14:1999;551-556.
21. Nishiyama M., Yamamoto W., Park J. S., Okamoto R., Hanaoka H., Takano H., Saito N., Matsukawa M., Shirasaka T., Kurihara M. Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves. Clin. Cancer Res. 5:1999;2620-2628.
22. Johnson M. R., Wang K., Tillmanns S., Albin N., Diasio R. B. Structural organization of the human dihydropyrimidine dehydrogenase gene. Cancer Res. 57:1997;1660-1663.
23. Johnson M. R., Yan J., Shao L., Albin N., Diasio R. B. Semi-automated radioassay for determination of dihydropyrimidine dehydrogenase (DPD) activity. Screening cancer patients for DPD deficiency, a condition associated with 5-fluorouracil toxicity. J. Chromatogr. B. 696:1997;183-191.
24. ABI PRISM 7700 Sequence Detection System. 1997;. p. 11-13.
25. Smith J. B., Lee H.-L., Smith L. Regulation of expression of sodium-calcium exchanger and plasma membrane calcium ATPase by protein kinases, glucocorticoids, and growth factors. Ann. NY Acad. Sci. 279:1996;258-271.
26. Bradford M. A. Rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;258-264.
27. Alwine J. C., Kemp D. J., Stark G. R. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc. Natl. Acad. Sci. USA. 74:1977;5350-5354.
28. Kafatos F. C., Jones C. W., Efstratiadis A. Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure. Nucleic Acids Res. 7:1979;1541-1552.
29. Berk A. J., Sharp P. A. Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell. 12:1977;721-732.
30. Sharp P. A., Berk A. J., Berget S. M. Transcription maps of adenovirus. Methods Enzymol. 65:1980;750-768.
31. Wang A. M., Doyle M. V., Mark D. F. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:1989;9717-9721.
32. Gilliland G., Perrin S., Blanchard K., Bunn H. F. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 87:1990;2725-2729.
33. Zimmermann K., Mannhalter J. W. Technical aspects of quantitative competitive PCR. Biotechniques. 21:1996;268-272.
34. Kimura M., Sakata S. F., Matoba Y., Matsuda K., Kontani Y., Kaneko M. Cloning of rat dihydropyrimidine dehydrogenase and correlation of its mRNA increase in the rat liver with age. J. Nutr. Sci. Vit. 44:1998;537-546.
35. Takechi T., Okabe H., Fujioka A., Murakami Y. Relationship between protein levels and gene expression of dihydropyrimidine dehydrogenase in human tumor cells during growth. Jpn. J. Cancer Res. 89:1998;1144-1153.
36. Johnston S. J., Ridge S. A., Cassidy J., McLeod H. L. Regulation of dihydropyrimidine dehydrogenase in colorectal cancer. Clin. Cancer Res. 5:1999;2566-2570.